Tandem Investment Partners LLC Increases Position in Danaher Corporation $DHR

Tandem Investment Partners LLC raised its position in Danaher Corporation (NYSE:DHR) by 12.5% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,460 shares of the conglomerate’s stock after purchasing an additional 385 shares during the quarter. Tandem Investment Partners LLC’s holdings in Danaher were worth $683,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. GHP Investment Advisors Inc. grew its stake in shares of Danaher by 396.0% in the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock worth $25,000 after acquiring an additional 99 shares in the last quarter. Sierra Ocean LLC grew its stake in shares of Danaher by 116.9% in the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock worth $29,000 after acquiring an additional 76 shares in the last quarter. Smallwood Wealth Investment Management LLC acquired a new position in shares of Danaher in the first quarter worth $31,000. Dunhill Financial LLC grew its stake in shares of Danaher by 68.4% in the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate’s stock worth $34,000 after acquiring an additional 67 shares in the last quarter. Finally, Costello Asset Management INC acquired a new position in shares of Danaher in the first quarter worth $41,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling at Danaher

In other news, Director Teri List sold 2,778 shares of the stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 11.10% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have commented on DHR shares. Wall Street Zen upgraded shares of Danaher from a “hold” rating to a “buy” rating in a research note on Friday, June 27th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Danaher in a research note on Saturday, September 27th. Evercore ISI lowered their target price on shares of Danaher from $230.00 to $226.00 and set an “outperform” rating for the company in a research note on Tuesday, July 8th. Bank of America lowered their target price on shares of Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a research note on Monday, September 22nd. Finally, Guggenheim reiterated a “buy” rating and set a $250.00 target price on shares of Danaher in a research note on Wednesday, July 23rd. Seventeen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $245.91.

Danaher Price Performance

Shares of DHR opened at $215.05 on Friday. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $279.41. The stock has a market cap of $153.98 billion, a PE ratio of 45.75, a price-to-earnings-growth ratio of 3.06 and a beta of 0.77. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. The firm has a fifty day moving average price of $200.19 and a 200 day moving average price of $197.33.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating analysts’ consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm had revenue of $5.94 billion during the quarter, compared to analysts’ expectations of $5.83 billion. During the same period in the previous year, the company earned $1.72 earnings per share. Danaher’s quarterly revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, sell-side analysts anticipate that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a dividend of $0.32 per share. The ex-dividend date is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio is 27.23%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.